Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Effects of NOS gene therapy on atherogenic markers in cholesterol-fed rabbits

July 8, 1999

Antiarrhythmic effect of Z-13752A, a dual ACE/NEP inhibitor, is mediated by bradykinin

July 7, 1999

New milrinone analogues exhibit superior inotropic activity and high safety

July 7, 1999

Dual-acting piperazines inhibit TNF-alpha production, stimulate IL-10 production

July 7, 1999

Cell Genesys and Mitotix make progress toward a gene therapy product for restenosis

July 7, 1999

King Pharmaceuticals and Medeva to copromote Altace cardiovascular treatment

July 7, 1999

Novel small-molecule macrophage SR-A antagonist described

July 7, 1999

Phase II testing of promising cardiovascular drug well under way at Merck

July 6, 1999

Animal studies with KC-12792 point to potential of NEP inhibitors in management of heart failure

July 6, 1999

Nesiritide is safe and effective in patients with symptomatic decompensated CHF

July 6, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...